Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sylvamo | SLVM | Jan 13, 2025 | 77.82 | +3.35 |
Symbotic | SYM | Jan 13, 2025 | 24.47 | -4.38 |
Synaptics | SYNA | Jan 13, 2025 | 75.34 | -0.84 |
Synaptogenix | SNPX | Jan 13, 2025 | 3.34 | +6.71 |
Synchronoss Technologies | SNCR | Jan 13, 2025 | 8.68 | +3.33 |
Synchrony Financial | SYF | Jan 13, 2025 | 64.81 | +1.63 |
Synchrony Financial Pref A | SYF-B | Jan 13, 2025 | 25.72 | -0.35 |
Synchrony Financial Pref A | SYF-A | Jan 13, 2025 | 19.00 | -1.30 |
Syndax Pharmaceuticals | SNDX | Jan 13, 2025 | 12.80 | -2.36 |
Synergetics Inc | FTGC | Jan 13, 2025 | 24.84 | +0.49 |
Synergy CHC | SNYR | Jan 13, 2025 | 4.49 | 0.00 |
Synlogic | SYBX | Jan 13, 2025 | 1.42 | -3.41 |
Synopsys | SNPS | Jan 13, 2025 | 487.43 | -1.04 |
Synovus Financial | SNV | Jan 13, 2025 | 51.89 | +1.81 |
Synovus Financial D Pref | SNV-D | Jan 13, 2025 | 24.97 | -0.20 |
Synovus Financial E Pref | SNV-E | Jan 13, 2025 | 25.72 | -0.43 |
Syntec Optics | OPTX | Jan 13, 2025 | 2.08 | -21.21 |
Sypris Solutions | SYPR | Jan 13, 2025 | 1.96 | -9.26 |
Syra Health | SYRA | Jan 13, 2025 | 0.52 | -13.58 |
Syros Pharmaceuticals | SYRS | Jan 13, 2025 | 0.21 | -5.69 |
Sysco | SYY | Jan 13, 2025 | 73.71 | +0.16 |
System1 A | SST | Jan 13, 2025 | 0.64 | -15.88 |
T Stamp A | IDAI | Jan 13, 2025 | 4.85 | -5.83 |
T-Mobile US | TMUS | Jan 13, 2025 | 213.46 | +1.02 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Jan 13, 2025 | 41.75 | -0.52 |
T. Rowe Price Dividend Growth ETF | TDVG | Jan 13, 2025 | 39.57 | +0.69 |
T. Rowe Price Equity Income ETF | TEQI | Jan 13, 2025 | 40.70 | +1.09 |
T. Rowe Price Group | TROW | Jan 13, 2025 | 110.63 | +1.92 |
T. Rowe Price Growth Stock ETF | TGRW | Jan 13, 2025 | 39.34 | -0.59 |
T2 Biosystems | TTOO | Jan 13, 2025 | 0.32 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.